Complex Ketones
Bioworld D-Fructose, 1 kg
A monosaccharide and isomer of glucose Specifications:High Purity GradeMoisture: <0.5%Chloride: <0.018%Sulfate: <0.025%Calcium and Magnesium: <0.005%Heavy metals (as Pb): <0.0005%HS Code : 17025000IUPAC_Name: FructoseMelting Point: 103 °CRTECS Number: LS7120000
Apexbio Technology LLC Bupropion hydrochloride 31677-93-7 50mg
Bupropion hydrochloride (CAS 31677-93-7) is a small-molecule aminoketone that acts as a dual inhibitor of norepinephrine and dopamine reuptake with IC values of 6 5 0 6 M and 3 4 0 4 M respectively It is widely utilized in research for its established roles in modulating monoaminergic neurotransmission associated with depression and smoking cessation In cellular studies bupropion hydrochloride has been shown to decrease cell viability in SH-SY5Y neuroblastoma cells selectively induce endoplasmic reticulum stress and activate JNK pathways leading to caspase 3-dependent apoptosis Additionally it has been reported to downregulate tyrosine hydroxylase expression impacting dopamine biosynthesis
Apexbio Technology LLC 3-Bromopyruvic acid(Synonyms: 3-Bromopyruvate, 3-BrPA, β-Bromopyruvic acid, β-Bromopyruvate, Bromopyruvic acid, Bromopyruvate), 1g, CAS: 1113-59-3.
3-Bromopyruvic acid (CAS 1113-59-3) abbreviated as 3-BP is a small molecule inhibitor that targets hexokinase II (HK2) an enzyme notably upregulated in cancerous cells By inhibiting HK2 activity (Ki 2 4 mM) 3-BP interferes with glycolytic energy metabolism leading to reduced tumor cell proliferation in hepatocellular carcinoma BEL-7402 cells In mouse xenograft models of hepatocellular carcinoma administration of 3-BP (50 mg/kg/day six days weekly for three weeks) results in decreased tumor growth and increased tumor necrosis This compound serves as a tool in oncology research particularly for studying glycolysis-dependent tumor metabolism
Apexbio Technology LLC 3-Bromopyruvic acid(Synonyms: 3-Bromopyruvate, 3-BrPA, β-Bromopyruvic acid, β-Bromopyruvate, Bromopyruvic acid, Bromopyruvate), 25g, CAS: 1113-59-3.
3-Bromopyruvic acid (CAS 1113-59-3) abbreviated as 3-BP is a small molecule inhibitor that targets hexokinase II (HK2) an enzyme notably upregulated in cancerous cells By inhibiting HK2 activity (Ki 2 4 mM) 3-BP interferes with glycolytic energy metabolism leading to reduced tumor cell proliferation in hepatocellular carcinoma BEL-7402 cells In mouse xenograft models of hepatocellular carcinoma administration of 3-BP (50 mg/kg/day six days weekly for three weeks) results in decreased tumor growth and increased tumor necrosis This compound serves as a tool in oncology research particularly for studying glycolysis-dependent tumor metabolism
Apexbio Technology LLC 3-Bromopyruvic acid(Synonyms: 3-Bromopyruvate, 3-BrPA, β-Bromopyruvic acid, β-Bromopyruvate, Bromopyruvic acid, Bromopyruvate), 10g, CAS: 1113-59-3.
3-Bromopyruvic acid (CAS 1113-59-3) abbreviated as 3-BP is a small molecule inhibitor that targets hexokinase II (HK2) an enzyme notably upregulated in cancerous cells By inhibiting HK2 activity (Ki 2 4 mM) 3-BP interferes with glycolytic energy metabolism leading to reduced tumor cell proliferation in hepatocellular carcinoma BEL-7402 cells In mouse xenograft models of hepatocellular carcinoma administration of 3-BP (50 mg/kg/day six days weekly for three weeks) results in decreased tumor growth and increased tumor necrosis This compound serves as a tool in oncology research particularly for studying glycolysis-dependent tumor metabolism
Apexbio Technology LLC 3-Bromopyruvic acid(Synonyms: 3-Bromopyruvate, 3-BrPA, β-Bromopyruvic acid, β-Bromopyruvate, Bromopyruvic acid, Bromopyruvate), 5g, CAS: 1113-59-3.
3-Bromopyruvic acid (CAS 1113-59-3) abbreviated as 3-BP is a small molecule inhibitor that targets hexokinase II (HK2) an enzyme notably upregulated in cancerous cells By inhibiting HK2 activity (Ki 2 4 mM) 3-BP interferes with glycolytic energy metabolism leading to reduced tumor cell proliferation in hepatocellular carcinoma BEL-7402 cells In mouse xenograft models of hepatocellular carcinoma administration of 3-BP (50 mg/kg/day six days weekly for three weeks) results in decreased tumor growth and increased tumor necrosis This compound serves as a tool in oncology research particularly for studying glycolysis-dependent tumor metabolism